28th Jul 2020 15:16
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 27 JULY 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,510,730 | 1.17% | 465,202 | 0.36% | ||
(2) | Derivatives (other than options): | ||||
355,000 | 0.28% | 383,659 | 0.30% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
(4) | TOTAL: | ||||
1,865,730 | 1.45% | 848,861 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 210.8300 USD |
| Purchase | 8 | 211.0700 USD |
| Purchase | 100 | 210.1500 USD |
| Purchase | 200 | 211.2400 USD |
| Purchase | 242 | 210.8978 USD |
| Purchase | 266 | 210.9518 USD |
| Purchase | 300 | 210.7900 USD |
| Purchase | 787 | 211.5095 USD |
| Purchase | 937 | 211.5100 USD |
| Purchase | 950 | 211.5606 USD |
| Purchase | 1,474 | 211.4862 USD |
| Purchase | 2,000 | 210.7437 USD |
| Purchase | 2,111 | 210.7839 USD |
| Purchase | 2,847 | 210.9882 USD |
| Purchase | 2,847 | 210.9881 USD |
| Purchase | 6,373 | 211.0467 USD |
| Purchase | 6,571 | 211.1577 USD |
| Sale | 2 | 210.8300 USD |
| Sale | 8 | 211.0700 USD |
| Sale | 10 | 211.5200 USD |
| Sale | 19 | 210.8700 USD |
| Sale | 24 | 211.4962 USD |
| Sale | 25 | 210.8900 USD |
| Sale | 100 | 211.8600 USD |
| Sale | 100 | 210.4575 USD |
| Sale | 100 | 210.3100 USD |
| Sale | 100 | 211.0100 USD |
| Sale | 100 | 211.0000 USD |
| Sale | 117 | 210.6135 USD |
| Sale | 142 | 211.2080 USD |
| Sale | 200 | 211.0050 USD |
| Sale | 200 | 210.9850 USD |
| Sale | 200 | 210.9900 USD |
| Sale | 202 | 210.9912 USD |
| Sale | 221 | 210.5095 USD |
| Sale | 256 | 210.9296 USD |
| Sale | 300 | 210.9933 USD |
| Sale | 300 | 210.9866 USD |
| Sale | 445 | 210.9722 USD |
| Sale | 800 | 210.9868 USD |
| Sale | 950 | 211.5606 USD |
| Sale | 1,700 | 211.5100 USD |
| Sale | 1,773 | 210.8294 USD |
| Sale | 1,869 | 210.8653 USD |
| Sale | 2,000 | 210.7436 USD |
| Sale | 2,847 | 210.9881 USD |
| Sale | 5,104 | 211.0880 USD |
| Sale | 7,826 | 211.2221 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 28 JULY 2020 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200728005673/en/
Copyright Business Wire 2020
Related Shares:
Barclays